More Frequent Activity Linked to Lower Perimenopause Symptom Scores

On October 14, 2026, The Menopause Society announced research linking more frequent physical activity with lower reported perimenopause symptom scores among Flo-app respondents. The findings were scheduled for presentation at the Society’s 2026 Annual Meeting in San Diego.

Does this change the role of exercise in perimenopause care?

The care framework remains individualized: movement can sit within a wider discussion of well-being and symptoms. Neither the Society’s announcement nor a separate review of exercise trials supports replacing personal medical care with exercise.

The update concerns the evidence behind that conversation. The Flo-app analysis examines how activity frequency relates to reported symptom burden. It adds a global observational finding to discussions of movement rather than announcing a new treatment standard.

What did the Flo-app study find?

The Menopause Society’s release describes a survey-based analysis with several distinct parts:

• The respondents came from many countries. The study included more than 1,800 Flo-app respondents from 87 countries across six continents. That gives the research an international scope and makes it relevant to questions about activity across different settings.
• Activity was reported as frequency. Respondents selected categories ranging from “not physically active” to “>5 days a week.” The analysis therefore examined how often people reported being active. Its central comparison was activity frequency alongside symptom burden.
• Symptoms were assessed with a named scale. Researchers used the Menopause Rating Scale, or MRS. It assessed severity across somatic, psychological and urogenital domains. This allowed the analysis to examine an overall symptom score alongside different areas of experience.
• More frequent activity was linked to lower overall scores. According to the Society, increasing activity frequency was associated with lower mean total MRS scores in the unadjusted analysis. “Mean” refers to the average score. “Unadjusted” means this particular result was reported before accounting for other factors in the statistical comparison.
• The apparent association was strongest for psychological symptoms. The release highlighted low mood, irritability and anxiety. This makes emotional well-being a particular focus of the announcement rather than treating every aspect of perimenopause as one undifferentiated outcome.
• The researchers identified other factors for their analysis. They used multivariable linear regression and prespecified potential confounders. These included age, body mass index and smoking status. The list also covered comorbidities, healthcare access and the country-level Socio-Demographic Index.

How does this compare with randomized exercise trials?

A separate report offers context from a different research design. On October 13, 2026, University College London (UCL) reported on a systematic review and meta-analysis of 12 randomized controlled trials involving more than 1,000 women in perimenopause or early postmenopause.

The UCL account described several findings:

• Aerobic activities were associated with psychological and quality-of-life benefits. The review reported reduced depressive symptoms and improved overall quality of life. These outcomes give the movement conversation a broader foundation than the Flo-app survey alone.
• Mind-body activities were associated with improved psychological quality of life. This is a distinct outcome from an overall perimenopause symptom score. Keeping those measures separate helps readers understand what each piece of research actually assessed.
• The studies covered varied forms of movement. Activities included walking, Zumba and aerobic exercise. Other examples were dance, taekwondo and yoga. Tai chi, Pilates and stretching also appeared in the review.

These findings concern activities studied in trials, while the Flo analysis concerns reported activity frequency. The two sources approach related questions from different directions.

What remains uncertain about the evidence?

The limits are specific and matter when translating the findings into health advice:

• The Flo study cannot establish cause and effect. More frequent activity was associated with lower symptom scores. Symptoms themselves could influence how active someone is, while other factors could influence both activity and symptom burden. The randomized-trial review provides separate context but does not validate the Flo study’s particular results.
• The size and statistical certainty of the Flo association are not available. The release gives no effect sizes, confidence intervals or p-values. It also provides no detailed adjusted results. The announcement therefore does not establish that the association was large, clinically meaningful or robust after adjustment.
• Important survey details remain unspecified. The release does not give survey dates, a response rate or respondent demographics. It does not explain how perimenopause status was established or whether activity was independently verified. International participation alone does not establish that the respondents represent all women in perimenopause.
• The domain-level wording contains an inconsistency. The release refers to an association across all three symptom domains but repeats “urogenital” where another domain appears intended. The clear findings are the reported overall association and the particular emphasis on psychological symptoms. More precise claims about each domain would go beyond that wording.
• The trial evidence has its own limitations. UCL’s researchers described a limited evidence base with substantial variation between studies. Many studies were judged at high risk of bias. They called for further research to determine which activities are most beneficial.
• Neither source establishes a personal exercise prescription. The evidence does not identify the best activity, intensity or frequency for a particular symptom. Schedules used in individual trials are examples of what researchers studied rather than a universal target for symptom relief.

What is the practical place for movement in symptom care?

The useful next step is a conversation about where manageable activity might fit within an individual’s wider care. The sources support discussing movement as one possible contributor to well-being while keeping the person’s symptoms and circumstances in view.

• Give emotional symptoms a clear place in the discussion. Low mood, irritability and anxiety were the psychological symptoms highlighted in the Society’s announcement. Bringing those experiences into a care conversation makes the concern more specific than simply saying that perimenopause feels difficult. Refemina’s coverage of broader conversations about emotional and cognitive symptoms offers related context.
• Discuss a manageable approach rather than copying a research category. The practical implication is to ask a qualified healthcare professional how activity might fit the individual situation. The research supports that discussion without setting a demanding performance target. For related reading, Refemina examines adapting movement around menopause symptoms.
• Keep persistent or disruptive symptoms visible. Movement can be part of a broader well-being conversation without becoming a reason to dismiss distress. The appropriate focus is the woman’s experience and the support she needs. Understanding which professionals can help with different care questions can help frame that conversation.
• Avoid turning the findings into a judgment about effort. A group-level association is not a measure of how well an individual is managing perimenopause. Women should not have to demonstrate an exercise routine before their symptoms are taken seriously. The constructive use of this research is to widen the discussion of support rather than narrow it to personal responsibility.

For readers, the distinction between an opportunity and an obligation matters. These findings offer a reason to discuss activity in relation to well-being. They do not make a woman’s symptom burden a verdict on her choices.

How is The Menopause Society interpreting the result?

Dr. Stephanie Faubion, medical director for The Menopause Society, described regular activity as a low-risk strategy that “may help” overall well-being.

That wording sets an appropriate tone for the announcement. It gives movement a place in the conversation without presenting the survey as a treatment promise. The emphasis belongs on a potentially useful option within broader care rather than an expectation that every woman should respond in the same way.

How might this shape future clinical conversations?

This research could make discussions of manageable movement more specific, particularly around psychological well-being, while keeping individualized symptom assessment at the centre of care.

How Refemina helps

Choosing a place for movement alongside symptom care leaves questions beyond an exercise schedule; Refemina addresses those questions through research-led midlife coverage. When conflicting menopause information blurs the difference between support and treatment, that editorial perspective helps readers understand hormonal change without reducing their well-being to a single activity or explanation.

Explore Resources

Sources

1. Higher physical activity frequency associated with lower symptom burden in perimenopause
2. Physical activity may improve mood and quality of life during menopause